Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Mouse PD-L1 (Programmed Death Ligand 1, B7-H1, PD-L1, CD274) In Vivo PLATINUM; Clone 10F.9G2; Isotype: Rat IgG2b κ
SDP

Supplier:  Leinco Technologies Inc P37125 MG

Encompass_Preferred

Specificity: Clone 10F.9G2 recognizes an epitope on mouse PD-L1. Antigen Distribution: PD-L1 is present on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes. Background:PD-L1 is a 40 kD type I transmembrane protein and is part of the B7 Ig superfamily. The interaction of PD-1 with its ligand PD-L1 is critical in the inhibition of T cell responses that include T cell proliferation and cytokine production. PD-L1 has been reported to costimulate T cell growth and cytokine production. Applications: (WB, B, FA) Clone 10F.9G2 has been shown to block the interaction between PD-L1 and PD-1 and between PD-L1 and B7-1. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6572


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.